Brooklyn FI LLC Invests $948,000 in Kenvue Inc. (NYSE:KVUE)

Brooklyn FI LLC acquired a new position in Kenvue Inc. (NYSE:KVUE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 41,824 shares of the company's stock, valued at approximately $948,000.

Other hedge funds also recently made changes to their positions in the company. Handelsbanken Fonder AB lifted its position in Kenvue by 2.9% in the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock valued at $15,846,000 after acquiring an additional 21,222 shares in the last quarter. Alberta Investment Management Corp increased its holdings in Kenvue by 23.2% in the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock worth $12,445,000 after acquiring an additional 109,700 shares in the last quarter. Longbow Finance SA boosted its position in shares of Kenvue by 5.0% in the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company's stock worth $5,990,000 after purchasing an additional 13,287 shares during the period. Steward Partners Investment Advisory LLC increased its stake in shares of Kenvue by 143.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock worth $1,023,000 after purchasing an additional 28,216 shares in the last quarter. Finally, CORDA Investment Management LLC. raised its position in shares of Kenvue by 1.4% during the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock valued at $26,754,000 after purchasing an additional 17,466 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts recently weighed in on KVUE shares. Evercore ISI initiated coverage on shares of Kenvue in a report on Monday. They issued an "in-line" rating and a $25.00 target price for the company. Canaccord Genuity Group increased their target price on Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research report on Wednesday, March 5th. Citigroup dropped their price target on Kenvue from $25.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, January 15th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $24.00 price objective on shares of Kenvue in a report on Monday, February 3rd. Finally, Piper Sandler upped their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research report on Monday, February 24th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Kenvue currently has an average rating of "Hold" and an average target price of $23.85.

Kenvue Trading Up 0.3 %

NYSE KVUE traded up $0.07 on Monday, hitting $23.38. 13,187,062 shares of the stock were exchanged, compared to its average volume of 16,157,921. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46. The firm has a market capitalization of $44.68 billion, a P/E ratio of 44.10, a P/E/G ratio of 2.62 and a beta of 1.25. The stock has a fifty day moving average price of $22.08 and a two-hundred day moving average price of $22.43.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.51%. The ex-dividend date was Wednesday, February 12th. Kenvue's payout ratio is 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.